Accurex Biomedical’s Post

🚨 Exciting News! We proudly announce that our Glucose Meter, Xpress Gluco+, has been published in the International Journal of Innovative and Applied Research! 🎉 This recognition highlights our unwavering commitment to delivering cutting-edge healthcare solutions. Here’s what makes Xpress Gluco+ a game-changer: ✅ Wide Measurement Range & Accuracy: Measures 20-800 mg/dL with 97% accuracy, ensuring reliability for diverse diabetic conditions. ✅ Cost-Effective: Includes 100 strips at a competitive price, lowering the cost per test. ✅ Advanced Features: Offers a 1,000-test memory, trend indicators, and a high hematocrit (HCT) range for advanced monitoring. ✅ Proudly Made in India: Designed specifically to meet the needs of Indian users. ✅ Ease of Use: Requires only 0.5 µL blood and delivers results in just 5 seconds. This milestone reinforces our mission to empower healthcare professionals and patients with innovative, affordable, and user-friendly solutions. Let’s connect to explore how Xpress Gluco+ can benefit your organization! #HealthcareInnovation #XpressGlucoPlus #AccurexBiomedical #MadeInIndia #DiabetesCare #GlucoseMonitoring

Impressive product for diabetic patients to monitor their health ..

Dipti Panjwani

Experienced IVD Professional | Leading Product Management, Marketing Strategy, and GP Analysis

2d

Congratulations on this remarkable achievement! Xpress Gluco+ is truly a game-changer with its accuracy, affordability, and user-friendly features. Proud to see innovative, Made-in-India solutions making a global impact!

Krishan Kant Pande

Product Specialist at Metrohm India Limited

1d

Congratulations 👏🎉

Like
Reply
Dr. Habibulla Imran

Postdoctoral Researcher at Jeonbuk National University, Korea

2d

Congratulations anna

Like
Reply
Rahul Kumar

Senior Researcher | IVD | POC Biosensor | Assay Development | Bio-Sensor Development | Class B & Class C Medical Devices | Six Sigma Yellow Belt

19h

This is great! Congratulations

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics